AQST
Price
$2.51
Change
+$0.01 (+0.40%)
Updated
Apr 17 closing price
Capitalization
383.26M
16 days until earnings call
SIGA
Price
$5.99
Change
+$0.07 (+1.18%)
Updated
Apr 17 closing price
Capitalization
608.54M
12 days until earnings call
Ad is loading...

AQST vs SIGA

Header iconAQST vs SIGA Comparison
Open Charts AQST vs SIGABanner chart's image
Aquestive Therapeutics
Price$2.51
Change+$0.01 (+0.40%)
Volume$1.11M
Capitalization383.26M
SIGA Technologies
Price$5.99
Change+$0.07 (+1.18%)
Volume$580.4K
Capitalization608.54M
AQST vs SIGA Comparison Chart
Loading...
AQST
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SIGA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AQST vs. SIGA commentary
Apr 20, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AQST is a Hold and SIGA is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 20, 2025
Stock price -- (AQST: $2.51 vs. SIGA: $5.99)
Brand notoriety: AQST and SIGA are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: AQST: 64% vs. SIGA: 109%
Market capitalization -- AQST: $383.26M vs. SIGA: $608.54M
AQST [@Pharmaceuticals: Other] is valued at $383.26M. SIGA’s [@Pharmaceuticals: Other] market capitalization is $608.54M. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.63B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AQST’s FA Score shows that 0 FA rating(s) are green whileSIGA’s FA Score has 2 green FA rating(s).

  • AQST’s FA Score: 0 green, 5 red.
  • SIGA’s FA Score: 2 green, 3 red.
According to our system of comparison, SIGA is a better buy in the long-term than AQST.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AQST’s TA Score shows that 4 TA indicator(s) are bullish while SIGA’s TA Score has 6 bullish TA indicator(s).

  • AQST’s TA Score: 4 bullish, 6 bearish.
  • SIGA’s TA Score: 6 bullish, 2 bearish.
According to our system of comparison, SIGA is a better buy in the short-term than AQST.

Price Growth

AQST (@Pharmaceuticals: Other) experienced а +3.72% price change this week, while SIGA (@Pharmaceuticals: Other) price change was +1.18% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +3.78%. For the same industry, the average monthly price growth was -5.82%, and the average quarterly price growth was -13.07%.

Reported Earning Dates

AQST is expected to report earnings on Aug 12, 2025.

SIGA is expected to report earnings on May 01, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (+3.78% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SIGA($609M) has a higher market cap than AQST($383M). SIGA YTD gains are higher at: -0.333 vs. AQST (-29.494). SIGA has higher annual earnings (EBITDA): 84.2M vs. AQST (1.18M). SIGA has more cash in the bank: 150M vs. AQST (23.9M). SIGA has less debt than AQST: SIGA (564K) vs AQST (33.3M). SIGA has higher revenues than AQST: SIGA (140M) vs AQST (50.6M).
AQSTSIGAAQST / SIGA
Capitalization383M609M63%
EBITDA1.18M84.2M1%
Gain YTD-29.494-0.3338,863%
P/E RatioN/A9.24-
Revenue50.6M140M36%
Total Cash23.9M150M16%
Total Debt33.3M564K5,904%
FUNDAMENTALS RATINGS
AQST vs SIGA: Fundamental Ratings
AQST
SIGA
OUTLOOK RATING
1..100
3936
VALUATION
overvalued / fair valued / undervalued
1..100
36
Fair valued
1
Undervalued
PROFIT vs RISK RATING
1..100
8984
SMR RATING
1..100
10033
PRICE GROWTH RATING
1..100
8457
P/E GROWTH RATING
1..100
10067
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

SIGA's Valuation (1) in the Pharmaceuticals Other industry is somewhat better than the same rating for AQST (36) in the Pharmaceuticals Major industry. This means that SIGA’s stock grew somewhat faster than AQST’s over the last 12 months.

SIGA's Profit vs Risk Rating (84) in the Pharmaceuticals Other industry is in the same range as AQST (89) in the Pharmaceuticals Major industry. This means that SIGA’s stock grew similarly to AQST’s over the last 12 months.

SIGA's SMR Rating (33) in the Pharmaceuticals Other industry is significantly better than the same rating for AQST (100) in the Pharmaceuticals Major industry. This means that SIGA’s stock grew significantly faster than AQST’s over the last 12 months.

SIGA's Price Growth Rating (57) in the Pharmaceuticals Other industry is in the same range as AQST (84) in the Pharmaceuticals Major industry. This means that SIGA’s stock grew similarly to AQST’s over the last 12 months.

SIGA's P/E Growth Rating (67) in the Pharmaceuticals Other industry is somewhat better than the same rating for AQST (100) in the Pharmaceuticals Major industry. This means that SIGA’s stock grew somewhat faster than AQST’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AQSTSIGA
RSI
ODDS (%)
Bullish Trend 3 days ago
86%
N/A
Stochastic
ODDS (%)
Bullish Trend 3 days ago
83%
Bearish Trend 3 days ago
81%
Momentum
ODDS (%)
Bearish Trend 3 days ago
84%
Bullish Trend 3 days ago
74%
MACD
ODDS (%)
Bearish Trend 3 days ago
83%
Bullish Trend 3 days ago
80%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
82%
Bullish Trend 3 days ago
78%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
85%
Bullish Trend 3 days ago
78%
Advances
ODDS (%)
Bullish Trend 5 days ago
85%
Bullish Trend 6 days ago
78%
Declines
ODDS (%)
Bearish Trend 12 days ago
89%
Bearish Trend 4 days ago
79%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
89%
Bullish Trend 3 days ago
77%
Aroon
ODDS (%)
Bearish Trend 4 days ago
81%
N/A
View a ticker or compare two or three
Ad is loading...
AQST
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SIGA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME26.780.53
+2.02%
GameStop Corp
AAPL196.982.71
+1.39%
Apple
BTC.X85063.414000612.609400
+0.73%
Bitcoin cryptocurrency
SPY525.66N/A
N/A
SPDR® S&P 500® ETF
TSLA241.37-0.18
-0.07%
Tesla

AQST and

Correlation & Price change

A.I.dvisor tells us that AQST and EOLS have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that AQST and EOLS's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AQST
1D Price
Change %
AQST100%
+0.40%
EOLS - AQST
31%
Poorly correlated
+6.73%
OGI - AQST
29%
Poorly correlated
+2.88%
SCYX - AQST
28%
Poorly correlated
-0.91%
ETON - AQST
26%
Poorly correlated
+1.85%
SUPN - AQST
26%
Poorly correlated
+0.16%
More

SIGA and

Correlation & Price change

A.I.dvisor tells us that SIGA and EBS have been poorly correlated (+27% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SIGA and EBS's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SIGA
1D Price
Change %
SIGA100%
+1.18%
EBS - SIGA
27%
Poorly correlated
N/A
CURR - SIGA
26%
Poorly correlated
+4.76%
SUPN - SIGA
23%
Poorly correlated
+0.16%
SBFM - SIGA
23%
Poorly correlated
+2.46%
AQST - SIGA
23%
Poorly correlated
+0.40%
More